← brief for 2026-08-17 · Slowing decline

Therapies for Cardiovascular-Kidney-Liver-Metabolic Syndrome: Reappraisal of Fibrates.

Article No results yet Peer reviewed

Key takeaways

This is a review, not a new study. Doctors took a fresh look at old cholesterol drugs called fibrates for people who have heart, kidney, liver, and blood sugar problems all at once. It sums up what is known about these and newer drugs, but reports no new results.

Who did this work

Anagnostopoulou V · Travlos CK · Marinho LL · Mavrakanas TA · Ferreira JP · Sharma A

Source

Article · PubMed, fibrosis reversal · 2026 Aug 17
https://pubmed.ncbi.nlm.nih.gov/42608342/